Lord’s Mark Industries has won Central Licensing Authority clearance for its LordsMed HIV 1&2 Self Test, joining a limited group of just nine global companies with Class D in-vitro diagnostic self-test approval. Exports are slated to start in June 2026 to Africa, the EU and South America, with the firm targeting major international markets.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
